Wells Fargo’s Amgen AMGN Stock Holding History

Wells Fargo’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.49B	Sell	7,088,010 -22,683	-0.3%	-$8.09M	0.47%	34
2025 Q4	$2.33B	Sell	7,110,693 -46,680	-0.7%	-$14.8M	0.42%	41
2025 Q3	$2.02B	Sell	7,157,373 -153,586	-2%	-$44.5M	0.38%	56
2025 Q2	$2.04B	Buy	7,310,959 +59,477	+0.8%	+$16.8M	0.42%	48
2025 Q1	$2.26B	Buy	7,251,482 +116,877	+2%	+$34.5M	0.51%	41
2024 Q4	$1.86B	Sell	7,134,605 -355,575	-5%	-$105M	0.42%	51
2024 Q3	$2.41B	Sell	7,490,180 -187,409	-2%	-$61.3M	0.55%	38
2024 Q2	$2.4B	Buy	7,677,589 +174,907	+2%	+$51.4M	0.58%	35
2024 Q1	$2.13B	Buy	7,502,682 +13,905	+0.2%	+$4.07M	0.51%	44
2023 Q4	$2.16B	Sell	7,488,777 -92,642	-1%	-$25.2M	0.56%	37
2023 Q3	$2.04B	Sell	7,581,419 -89,294	-1%	-$22.3M	0.6%	33
2023 Q2	$1.7B	Buy	7,670,713 +98,374	+1%	+$22.8M	0.47%	48
2023 Q1	$1.83B	Buy	7,572,339 +178,976	+2%	+$43.9M	0.53%	37
2022 Q4	$1.94B	Sell	7,393,363 -102,594	-1%	-$27.5M	0.58%	33
2022 Q3	$1.69B	Sell	7,495,957 -12,942	-0.2%	-$3.14M	0.55%	34
2022 Q2	$1.83B	Sell	7,508,899 -98,549	-1%	-$24.1M	0.57%	33
2022 Q1	$1.84B	Buy	7,607,448 +944,683	+14%	+$217M	0.47%	41
2021 Q4	$1.5B	Sell	6,662,765 -269,747	-4%	-$56.9M	0.37%	55
2021 Q3	$1.47B	Sell	6,932,512 -195,083	-3%	-$44.9M	0.32%	56
2021 Q2	$1.74B	Sell	7,127,595 -511,012	-7%	-$126M	0.38%	44
2021 Q1	$1.9B	Buy	7,638,607 +25,489	+0.3%	+$6.08M	0.43%	34
2020 Q4	$1.75B	Buy	7,613,118 +194,587	+3%	+$44.9M	0.42%	40
2020 Q3	$1.89B	Sell	7,418,531 -31,153	-0.4%	-$7.72M	0.52%	32
2020 Q2	$1.76B	Buy	7,449,684 +276,284	+4%	+$63M	0.51%	30
2020 Q1	$1.45B	Buy	7,173,400 +43,582	+0.6%	+$9.52M	0.5%	35
2019 Q4	$1.72B	Sell	7,129,818 -246,743	-3%	-$54.4M	0.46%	34
2019 Q3	$1.43B	Sell	7,376,561 -45,405	-0.6%	-$8.72M	0.4%	46
2019 Q2	$1.37B	Sell	7,421,966 -105,117	-1%	-$18.8M	0.39%	43
2019 Q1	$1.43B	Buy	7,527,083 +1,403,169	+23%	+$268M	0.43%	40
2018 Q4	$1.19B	Buy	6,123,914 +107,129	+2%	+$20.9M	0.4%	45
2018 Q3	$1.25B	Sell	6,016,785 -14,636	-0.2%	-$2.88M	0.35%	49
2018 Q2	$1.11B	Sell	6,031,421 -401,943	-6%	-$71.1M	0.33%	57
2018 Q1	$1.1B	Sell	6,433,364 -765,792	-11%	-$141M	0.32%	58
2017 Q4	$1.25B	Buy	7,199,156 +536,081	+8%	+$94.9M	0.36%	49
2017 Q3	$1.24B	Sell	6,663,075 -77,071	-1%	-$13.7M	0.38%	47
2017 Q2	$1.16B	Buy	6,740,146 +219,294	+3%	+$35.7M	0.37%	44
2017 Q1	$1.07B	Buy	6,520,852 +441,674	+7%	+$73.4M	0.35%	52
2016 Q4	$889M	Buy	6,079,178 +184,633	+3%	+$27.8M	0.31%	59
2016 Q3	$983M	Buy	5,894,545 +617,957	+12%	+$104M	0.36%	51
2016 Q2	$803M	Buy	5,276,588 +415,661	+9%	+$64.6M	0.31%	64
2016 Q1	$729M	Buy	4,860,927 +298,724	+7%	+$44.4M	0.29%	67
2015 Q4	$741M	Buy	4,562,203 +2,041,774	+81%	+$321M	0.29%	66
2015 Q3	$349M	Buy	2,520,429 +51,161	+2%	+$8.06M	0.15%	169
2015 Q2	$379M	Buy	2,469,268 +286,953	+13%	+$46M	0.15%	162
2015 Q1	$349M	Buy	2,182,315 +21,705	+1%	+$3.42M	0.14%	184
2014 Q4	$344M	Sell	2,160,610 -480,380	-18%	-$74.9M	0.13%	187
2014 Q3	$371M	Buy	2,640,990 +402,536	+18%	+$52.6M	0.16%	157
2014 Q2	$265M	Sell	2,238,454 -46,988	-2%	-$5.44M	0.11%	231
2014 Q1	$282M	Buy	2,285,442 +180,940	+9%	+$21.9M	0.12%	211
2013 Q4	$240M	Sell	2,104,502 -115,634	-5%	-$13.2M	0.1%	242
2013 Q3	$248M	Sell	2,220,136 -1,232,550	-36%	-$134M	0.12%	218
2013 Q2	$341M	Buy	+3,452,686	New	+$358M	0.18%	144

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo's AMGN Position: Q1 2026 in Review

Wells Fargo reduced its Amgen (AMGN) stake by 0.32% in Q1 2026, selling an estimated $8.09M and leaving 7,088,010 shares worth $2.49B. The position accounts for 0.47% of the portfolio, ranked #34.

Wells Fargo first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Wells Fargo held 7,088,010 shares of Amgen worth $2.49B as of Q1 2026.
Wells Fargo sold 22,683 Amgen shares in Q1 2026, an estimated $8.09M.
Amgen made up 0.47% of Wells Fargo's portfolio in Q1 2026, its #34 holding.
Wells Fargo first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.